Adeira Pharma
Pre-clinicalAdeira Pharma has developed proprietary targeted nanoparticle formulations for small molecule, protein, nucleic acid and antibody therapeutics. The capabilities of this technology have been amply demonstrated with existing therapeutics that have historically posed formidable formulation challenges, resulting in vigorous efficacy and reduced toxicity in animal models of disease.
About
Adeira Pharma has developed proprietary targeted nanoparticle formulations for small molecule, protein, nucleic acid and antibody therapeutics. The capabilities of this technology have been amply demonstrated with existing therapeutics that have historically posed formidable formulation challenges, resulting in vigorous efficacy and reduced toxicity in animal models of disease.
Company Info
Contact
Sectors
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile